FDA Inspection 1074882 — Ascent Pharmaceuticals Inc

Ascent Pharmaceuticals Inc — FEI 3009518416

The FDA completed an inspection of Ascent Pharmaceuticals Inc on Nov 7, 2018 in Central Islip, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Nov 7, 2018
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Central Islip, NY (United States)

Additional details

Postmarket Adverse Drug Experience (PADE)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.